Endogenous immunoreactive ouabain-like and digoxin-like factors in reduced renal mass hypertensive rats

Hypertension Research

Volumn 21, Issue 3, 1998, Pages 193-199

  Takada, Tamaki ^a   Nakagawa, Motoya ^a   Ura, Nobuyuki ^a   Kaide, Jun Ichi ^a   Yoshida, Hideaki ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Digoxin; Hypertension; Ouabain; Reduced renal mass

Indexed keywords

DIGITALIS LIKE FACTOR; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERTENSION; KIDNEY MASS; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; URINE VOLUME;

EID: 0031663801     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.21.193     Document Type: Article

References (29)

1. Haddy FJ, Overbeck HW: The role of humoral agents in volume expanded hypertension. Life Sci 1976; 19: 935-947.
2. Haupert GT, Sancho JM: Sodium transport inhibitor from bovine hypothalamus. Proc Natl Acad Sci USA 1979; 76: 4658-4660.
3. + -ATPase inhibitors from acute volume expanded hog plasma. J Biol Chem 1985; 260: 9672-9677.
4. Kelly RA, O'Hara DS, Mitch WE, Smith TW: Identification of Na, K-ATPase inhibitors in human plasma as non-esterified fatty acids and lysophospholipids. J Biol Chem 1986; 261: 11704-11711.
5. Goto A, Ishiguro T, Yamada K, Ishii M, Yoshioka M: Isolation of a urinary digitalis-like factor indistinguishable from digoxin. Biochem Biophys Res Commun 1990; 3: 1093-1101.
6. Weinberg U, Dolev S, Werber MM: Identification and preliminary characterization of two human digitalis-like substances that are structurally related to digoxin and ouabain. Biochem Biophys Res Commun 1992; 188: 1024-1029.
7. Gruber KA, Whitaker JM, Bucklew VM Jr: Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature 1980; 287: 743-745.
8. Shimamoto K, Ura N, Ishiguro T, Nakagawa M, Iimura O: The role of natriuretic depressor systems on hypertensive mechanisms in reduced renal mass hypertensive rats. Hypertens Res 1995; 18 (Suppl I): S53-S57.
9. Saitoh S, Shimamoto K, Nakagawa M, et al: The pathophysiological role of digitalis-like substance in essential hypertension. J Hypertens 1988; 6 (Suppl 4): S360-S362.
10. Hamlyn JM, Harris DW, Ludens JH: Digitalis-like activity in human plasma: purification, affinity and mechanism. J Biol Chem 1989; 264: 7395-7404.
11. Ludens JH, Clark MA, DuCharme DW, et al: Purification of an endogenous digitalis-like factor from human plasma for structural analysis. Hypertension 1991; 17: 923-929.
12. Mathews WR, DuCharme DW, Hamlyn JM, et al: Mass spectral characterization of an endogenous digitalis-like factor from human plasma. Hypertension 1991; 17: 930-935.
13. Hamlyn JM, Blaustein MP, Bova S, et al: Identification and characterization of an ouabain-like compound from human plasma. Proc Natl Acad Sci USA 1991; 88: 6259-6263.
14. Harris DW, Clark MA, Fisher JF, et al: Development of an immunoassay for endogenous digitalis-like factor. Hypertension 1991; 17: 936-943.
15. de Wardener HE, Mill IH, Clapham WF, Hayter CJ: Studies on the efferent mechanism of sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci 1961; 21: 249-258.
16. +-ATPase? In: Proceedings of the Fourth International Congress on Nephrology. New York, Karger, 1969, p373.
17. Pamnani MB, Bryant HJ, Harder DR, Haddy FJ: Vascular smooth muscle membrane potentials in rats with one-kidney, one clip and reduced renal mass saline hypertension: the influence of a humoral sodium pump inhibitor. J Hypertens 1985; 3 (Suppl 3): S29-S31.
18. Huot SJ, Pamnani MB, Clough DL, Haddy FJ: The role of sodium intake, the Na-K pump and a ouabain-like humoral agent in the genesis of reduced renal mass hypertension. Am J Nephrol 1983; 3: 92-99.
19. Krep H, Price DA, Soszynski P, Tao Q-F, Graves SW, Hollenberg NK: Volume sensitive hypertension and the digoxin-like factor: reversal by a Fab directed against digoxin in DOCA-salt hypertensive rats. Am J Hypertens 1995; 8: 921-927.
20. Goto A, Yamada K, Yagi N, et al: Digitalis-like factors from human urine. J Cardiovasc Pharmacol 1993; 22 (Suppl 2): S58-S59.
21. Tymiak AA, Norman JA, Bolgar M, et al: Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci USA 1993; 90: 8189-8193.
22. Zhao N, Lo L-C, Berova N, et al: ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry 1995; 34: 9893-9896.
23. Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T: Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev 1992; 44: 377-395.
24. Shaikh IM, Lau BWC, Siegfried BA, et al: Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex. J Biol Chem 1991; 266: 13672-13678.
25. Nakagawa M, Shimamoto K, Matsuda K, et al: The transient increase of urinary digitalis-like substance excreted during excess sodium intake in reduced renal mass rats. Am J Hypertens 1990; 3: 873-875.
26. Tamura M, Harris TM, Phillip D, et al: Identification of two cardiac glycosides as Na-pump inhibitors in rat urine and diet. J Biol Chem 1994; 269: 11972-11979.
27. Yamada K, Goto A, Hui C, et al: Role of ouabainlike compound in rats with reduced renal mass-saline hypertension. Am J Physiol 1994; 266: H1357-H1362.
28. Guthrie GP Jr: Effects of digoxin on responsiveness to the pressor actions of angiotensin and norepinephrine in man, J Clin Endoclinol Metab 1984; 58: 76-80.
29. Yuan CM, Mannunta P, Hamlyn JM, et al: Long-term ouabain administration produces hypertension in rats. Hypertension 1993; 22: 178-187.